Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.
about
ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells.Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.
P2860
Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phosphorylated mTOR and YAP se ...... herapeutic targets in gliomas.
@en
Phosphorylated mTOR and YAP se ...... herapeutic targets in gliomas.
@nl
type
label
Phosphorylated mTOR and YAP se ...... herapeutic targets in gliomas.
@en
Phosphorylated mTOR and YAP se ...... herapeutic targets in gliomas.
@nl
prefLabel
Phosphorylated mTOR and YAP se ...... herapeutic targets in gliomas.
@en
Phosphorylated mTOR and YAP se ...... herapeutic targets in gliomas.
@nl
P2093
P2860
P1476
Phosphorylated mTOR and YAP se ...... herapeutic targets in gliomas.
@en
P2093
Xian-Chao Zhang
Xindong Liu
Xiu-Wu Bian
You-Hong Cui
Yu-Huan Tan
P2860
P2888
P304
P356
10.1038/LABINVEST.2017.70
P577
2017-07-31T00:00:00Z